- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Armed T cells with CAR for cancer immunotherapy ; volume:59 ; number:4 ; day:15 ; month:4 ; year:2016 ; pages:331-332 ; date:4.2016
Science China / Life sciences. Life sciences ; 59, Heft 4 (15.4.2016), 331-332, 4.2016
- Urheber
-
Wei, Yu-quan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-5047-0
- URN
-
urn:nbn:de:1111-2016041616039
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wei, Yu-quan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors